Peng, Qiuyue <br/><br/>
Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.  [electronic resource] 

 -  Cytokine  01 2019 
 - 144-154 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-0023 
<br/><br/><label>Standard No.: </label>10.1016/j.cyto.2018.06.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Differentiation--physiology<br/>Cell Line<br/>Humans<br/>Interferons--metabolism<br/>Interleukins--metabolism<br/>Leukocytes, Mononuclear--metabolism<br/>MAP Kinase Signaling System--physiology<br/>Mice<br/>Mice, Inbred C57BL<br/>NF-kappa B--metabolism<br/>NFATC Transcription Factors--metabolism<br/>Osteoclasts--metabolism<br/>Osteogenesis--physiology<br/>RANK Ligand--metabolism<br/>RAW 264.7 Cells<br/>STAT Transcription Factors--metabolism<br/>Signal Transduction--physiology